Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK relaunches West Nile virus surveillance:

This article was originally published in Clinica

Executive Summary

The UK's Health Protection Agency has launched its latest annual West Nile virus enhanced surveillance programme. The programme involves testing for WNV in blood and cerebrospinal fluid samples, taken from all patients with encephalitis or viral meningitis with no known cause. The HPA has requested that clinicians and laboratories refer relevant samples to the HPA's central laboratory in Porton Down. The scheme, which is in its fourth year, operates during the UK's summer months, when there is WNV activity in other countries, and is designed to screen those returning from countries where WNV has an impact, such as Africa, west and central Asia, Europe, the Middle East and North America.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058723

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel